Altimmune Stock Price on March 15, 2022
ALT Stock | USD 6.89 0.15 2.13% |
Below is the normalized historical share price chart for Altimmune extending back to October 06, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Altimmune stands at 6.89, as last reported on the 19th of April, with the highest price reaching 7.26 and the lowest price hitting 6.85 during the day.
If you're considering investing in Altimmune Stock, it is important to understand the factors that can impact its price. Altimmune secures Sharpe Ratio (or Efficiency) of -0.0493, which signifies that the company had a -0.0493% return per unit of risk over the last 3 months. Altimmune exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Altimmune's Standard Deviation of 7.3, mean deviation of 5.23, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide.
At this time, Altimmune's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 55.9 M in 2024, whereas Capital Stock is likely to drop 4,065 in 2024. . At this time, Altimmune's Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 3.24 in 2024, despite the fact that Price To Free Cash Flows Ratio is likely to grow to (7.48). Altimmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of October 2005 | 200 Day MA 5.873 | 50 Day MA 9.6322 | Beta 0.059 |
Altimmune |
Sharpe Ratio = -0.0493
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ALT |
Estimated Market Risk
7.15 actual daily | 63 63% of assets are less volatile |
Expected Return
-0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Altimmune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Altimmune by adding Altimmune to a well-diversified portfolio.
Price Book 2.9184 | Enterprise Value Ebitda (4.20) | Price Sales 1.3 K | Shares Float 70.3 M | Wall Street Target Price 21.25 |
Altimmune Valuation on March 15, 2022
It is possible to determine the worth of Altimmune on a given historical date. On March 15, 2022 Altimmune was worth 6.25 at the beginning of the trading date compared to the closed value of 6.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Altimmune stock. Still, in general, we apply an absolute valuation method to find Altimmune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Altimmune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Altimmune's related companies.
Open | High | Low | Close | Volume | |
04/04/2022 | 6.25 | 6.44 | 6.09 | 6.33 | 369,800 |
6.31 | 6.41 | 5.81 | 5.85 | 696,800 |
Backtest Altimmune | | | Altimmune History | | | Altimmune Valuation | Next |
Altimmune Trading Date Momentum on March 15, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Altimmune Fundamentals Correlations and Trends
By evaluating Altimmune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Altimmune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Altimmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Altimmune Stock history
Altimmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Altimmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Altimmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Altimmune stock prices may prove useful in developing a viable investing in Altimmune
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 53.2 M | 55.9 M | |
Net Loss | -76.2 M | -72.4 M |
Altimmune Quarterly Net Working Capital |
|
Altimmune Stock Technical Analysis
Altimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Altimmune Period Price Range
Low | April 4, 2022
| High |
6.25 | 6.33 |
Altimmune April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Altimmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Altimmune shares will generate the highest return on investment. By undertsting and applying Altimmune stock market strength indicators, traders can identify Altimmune entry and exit signals to maximize returns
Accumulation Distribution | 20097.83 | |||
Daily Balance Of Power | 0.2286 | |||
Rate Of Daily Change | 1.01 | |||
Day Median Price | 6.27 | |||
Day Typical Price | 6.29 | |||
Price Action Indicator | 0.1 | |||
Period Momentum Indicator | 0.56 |
Altimmune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Altimmune's price direction in advance. Along with the technical and fundamental analysis of Altimmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Altimmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.65) | |||
Total Risk Alpha | (1.12) | |||
Treynor Ratio | (0.11) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Altimmune Stock analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Altimmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Revenue Per Share 0.008 | Quarterly Revenue Growth 180 | Return On Assets (0.25) | Return On Equity (0.47) |
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Altimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.